The Market Reports

Index

1 Prostate Cancer Drugs Market Overview
1.1 Product Overview and Scope of Prostate Cancer Drugs
1.2 Prostate Cancer Drugs Segment by Type
1.2.1 Global Prostate Cancer Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Hormonal Therapy
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.2.5 Targeted Therapy
1.3 Prostate Cancer Drugs Segment by Application
1.3.1 Global Prostate Cancer Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Global Prostate Cancer Drugs Market Size Estimates and Forecasts
1.4.1 Global Prostate Cancer Drugs Revenue 2016-2027
1.4.2 Global Prostate Cancer Drugs Sales 2016-2027
1.4.3 Prostate Cancer Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Prostate Cancer Drugs Market Competition by Manufacturers
2.1 Global Prostate Cancer Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Prostate Cancer Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Prostate Cancer Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Prostate Cancer Drugs Manufacturing Sites, Area Served, Product Type
2.5 Prostate Cancer Drugs Market Competitive Situation and Trends
2.5.1 Prostate Cancer Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Prostate Cancer Drugs Players Market Share by Revenue
2.5.3 Global Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Prostate Cancer Drugs Retrospective Market Scenario by Region
3.1 Global Prostate Cancer Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Prostate Cancer Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Prostate Cancer Drugs Market Facts & Figures by Country
3.3.1 North America Prostate Cancer Drugs Sales by Country
3.3.2 North America Prostate Cancer Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Prostate Cancer Drugs Market Facts & Figures by Country
3.4.1 Europe Prostate Cancer Drugs Sales by Country
3.4.2 Europe Prostate Cancer Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Prostate Cancer Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Prostate Cancer Drugs Sales by Region
3.5.2 Asia Pacific Prostate Cancer Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Prostate Cancer Drugs Market Facts & Figures by Country
3.6.1 Latin America Prostate Cancer Drugs Sales by Country
3.6.2 Latin America Prostate Cancer Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Prostate Cancer Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Prostate Cancer Drugs Sales by Country
3.7.2 Middle East and Africa Prostate Cancer Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Prostate Cancer Drugs Historic Market Analysis by Type
4.1 Global Prostate Cancer Drugs Sales Market Share by Type (2016-2021)
4.2 Global Prostate Cancer Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Prostate Cancer Drugs Price by Type (2016-2021)

5 Global Prostate Cancer Drugs Historic Market Analysis by Application
5.1 Global Prostate Cancer Drugs Sales Market Share by Application (2016-2021)
5.2 Global Prostate Cancer Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Prostate Cancer Drugs Price by Application (2016-2021)

6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 AbbVie Prostate Cancer Drugs Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Astellas Pharma
6.2.1 Astellas Pharma Corporation Information
6.2.2 Astellas Pharma Description and Business Overview
6.2.3 Astellas Pharma Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Astellas Pharma Prostate Cancer Drugs Product Portfolio
6.2.5 Astellas Pharma Recent Developments/Updates
6.3 Astra Zeneca
6.3.1 Astra Zeneca Corporation Information
6.3.2 Astra Zeneca Description and Business Overview
6.3.3 Astra Zeneca Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Astra Zeneca Prostate Cancer Drugs Product Portfolio
6.3.5 Astra Zeneca Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Johnson & Johnson Prostate Cancer Drugs Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Sanofi Prostate Cancer Drugs Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 GlaxoSmithKline Prostate Cancer Drugs Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Merck Group
6.6.1 Merck Group Corporation Information
6.6.2 Merck Group Description and Business Overview
6.6.3 Merck Group Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Merck Group Prostate Cancer Drugs Product Portfolio
6.7.5 Merck Group Recent Developments/Updates
6.8 Novartis
6.8.1 Novartis Corporation Information
6.8.2 Novartis Description and Business Overview
6.8.3 Novartis Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Novartis Prostate Cancer Drugs Product Portfolio
6.8.5 Novartis Recent Developments/Updates
6.9 Amgen
6.9.1 Amgen Corporation Information
6.9.2 Amgen Description and Business Overview
6.9.3 Amgen Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Amgen Prostate Cancer Drugs Product Portfolio
6.9.5 Amgen Recent Developments/Updates
6.10 Bayer HealthCare
6.10.1 Bayer HealthCare Corporation Information
6.10.2 Bayer HealthCare Description and Business Overview
6.10.3 Bayer HealthCare Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Bayer HealthCare Prostate Cancer Drugs Product Portfolio
6.10.5 Bayer HealthCare Recent Developments/Updates
6.11 Ferring Pharmaceutical
6.11.1 Ferring Pharmaceutical Corporation Information
6.11.2 Ferring Pharmaceutical Prostate Cancer Drugs Description and Business Overview
6.11.3 Ferring Pharmaceutical Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Ferring Pharmaceutical Prostate Cancer Drugs Product Portfolio
6.11.5 Ferring Pharmaceutical Recent Developments/Updates
6.12 Janssen Pharmaceuticals
6.12.1 Janssen Pharmaceuticals Corporation Information
6.12.2 Janssen Pharmaceuticals Prostate Cancer Drugs Description and Business Overview
6.12.3 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Janssen Pharmaceuticals Prostate Cancer Drugs Product Portfolio
6.12.5 Janssen Pharmaceuticals Recent Developments/Updates
6.13 Endo Pharmaceuticals
6.13.1 Endo Pharmaceuticals Corporation Information
6.13.2 Endo Pharmaceuticals Prostate Cancer Drugs Description and Business Overview
6.13.3 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Endo Pharmaceuticals Prostate Cancer Drugs Product Portfolio
6.13.5 Endo Pharmaceuticals Recent Developments/Updates
6.14 BMS
6.14.1 BMS Corporation Information
6.14.2 BMS Prostate Cancer Drugs Description and Business Overview
6.14.3 BMS Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.14.4 BMS Prostate Cancer Drugs Product Portfolio
6.14.5 BMS Recent Developments/Updates
6.15 Takeda Pharmaceuticals
6.15.1 Takeda Pharmaceuticals Corporation Information
6.15.2 Takeda Pharmaceuticals Prostate Cancer Drugs Description and Business Overview
6.15.3 Takeda Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Takeda Pharmaceuticals Prostate Cancer Drugs Product Portfolio
6.15.5 Takeda Pharmaceuticals Recent Developments/Updates
6.16 Northwest Biotherapeutics
6.16.1 Northwest Biotherapeutics Corporation Information
6.16.2 Northwest Biotherapeutics Prostate Cancer Drugs Description and Business Overview
6.16.3 Northwest Biotherapeutics Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Northwest Biotherapeutics Prostate Cancer Drugs Product Portfolio
6.16.5 Northwest Biotherapeutics Recent Developments/Updates
6.17 Teva Pharmaceutical
6.17.1 Teva Pharmaceutical Corporation Information
6.17.2 Teva Pharmaceutical Prostate Cancer Drugs Description and Business Overview
6.17.3 Teva Pharmaceutical Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Teva Pharmaceutical Prostate Cancer Drugs Product Portfolio
6.17.5 Teva Pharmaceutical Recent Developments/Updates
6.18 Boehringer Ingelheim
6.18.1 Boehringer Ingelheim Corporation Information
6.18.2 Boehringer Ingelheim Prostate Cancer Drugs Description and Business Overview
6.18.3 Boehringer Ingelheim Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Boehringer Ingelheim Prostate Cancer Drugs Product Portfolio
6.18.5 Boehringer Ingelheim Recent Developments/Updates
6.19 Foresee Pharmaceuticals
6.19.1 Foresee Pharmaceuticals Corporation Information
6.19.2 Foresee Pharmaceuticals Prostate Cancer Drugs Description and Business Overview
6.19.3 Foresee Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Foresee Pharmaceuticals Prostate Cancer Drugs Product Portfolio
6.19.5 Foresee Pharmaceuticals Recent Developments/Updates
6.20 Tokai Pharmaceuticals
6.20.1 Tokai Pharmaceuticals Corporation Information
6.20.2 Tokai Pharmaceuticals Prostate Cancer Drugs Description and Business Overview
6.20.3 Tokai Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Tokai Pharmaceuticals Prostate Cancer Drugs Product Portfolio
6.20.5 Tokai Pharmaceuticals Recent Developments/Updates
6.21 Spectrum Pharmaceuticals
6.21.1 Spectrum Pharmaceuticals Corporation Information
6.21.2 Spectrum Pharmaceuticals Prostate Cancer Drugs Description and Business Overview
6.21.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Spectrum Pharmaceuticals Prostate Cancer Drugs Product Portfolio
6.21.5 Spectrum Pharmaceuticals Recent Developments/Updates

7 Prostate Cancer Drugs Manufacturing Cost Analysis
7.1 Prostate Cancer Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Prostate Cancer Drugs
7.4 Prostate Cancer Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Prostate Cancer Drugs Distributors List
8.3 Prostate Cancer Drugs Customers

9 Prostate Cancer Drugs Market Dynamics
9.1 Prostate Cancer Drugs Industry Trends
9.2 Prostate Cancer Drugs Growth Drivers
9.3 Prostate Cancer Drugs Market Challenges
9.4 Prostate Cancer Drugs Market Restraints

10 Global Market Forecast
10.1 Prostate Cancer Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Prostate Cancer Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Prostate Cancer Drugs by Type (2022-2027)
10.2 Prostate Cancer Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Prostate Cancer Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Prostate Cancer Drugs by Application (2022-2027)
10.3 Prostate Cancer Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Prostate Cancer Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Prostate Cancer Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Prostate Cancer Drugs Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Prostate Cancer Drugs Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Prostate Cancer Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Prostate Cancer Drugs Covered in This Study
Table 5. Global Prostate Cancer Drugs Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Prostate Cancer Drugs Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Prostate Cancer Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Prostate Cancer Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Prostate Cancer Drugs Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Prostate Cancer Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Prostate Cancer Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Prostate Cancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Prostate Cancer Drugs Sales by Region (2016-2021) & (K MT)
Table 16. Global Prostate Cancer Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Prostate Cancer Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Prostate Cancer Drugs Sales by Country (2016-2021) & (K MT)
Table 19. North America Prostate Cancer Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Prostate Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Prostate Cancer Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Prostate Cancer Drugs Sales by Country (2016-2021) & (K MT)
Table 23. Europe Prostate Cancer Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Prostate Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Prostate Cancer Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Prostate Cancer Drugs Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Prostate Cancer Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Prostate Cancer Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Prostate Cancer Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Prostate Cancer Drugs Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Prostate Cancer Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Prostate Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Prostate Cancer Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Prostate Cancer Drugs Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Prostate Cancer Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Prostate Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Prostate Cancer Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Prostate Cancer Drugs Sales (K MT) by Type (2016-2021)
Table 39. Global Prostate Cancer Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Prostate Cancer Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Prostate Cancer Drugs Revenue Share by Type (2016-2021)
Table 42. Global Prostate Cancer Drugs Price (USD/MT) by Type (2016-2021)
Table 43. Global Prostate Cancer Drugs Sales (K MT) by Application (2016-2021)
Table 44. Global Prostate Cancer Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Prostate Cancer Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Prostate Cancer Drugs Revenue Share by Application (2016-2021)
Table 47. Global Prostate Cancer Drugs Price (USD/MT) by Application (2016-2021)
Table 48. AbbVie Corporation Information
Table 49. AbbVie Description and Business Overview
Table 50. AbbVie Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. AbbVie Prostate Cancer Drugs Product
Table 52. AbbVie Recent Developments/Updates
Table 53. Astellas Pharma Corporation Information
Table 54. Astellas Pharma Description and Business Overview
Table 55. Astellas Pharma Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Astellas Pharma Prostate Cancer Drugs Product
Table 57. Astellas Pharma Recent Developments/Updates
Table 58. Astra Zeneca Corporation Information
Table 59. Astra Zeneca Description and Business Overview
Table 60. Astra Zeneca Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Astra Zeneca Prostate Cancer Drugs Product
Table 62. Astra Zeneca Recent Developments/Updates
Table 63. Johnson & Johnson Corporation Information
Table 64. Johnson & Johnson Description and Business Overview
Table 65. Johnson & Johnson Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Johnson & Johnson Prostate Cancer Drugs Product
Table 67. Johnson & Johnson Recent Developments/Updates
Table 68. Sanofi Corporation Information
Table 69. Sanofi Description and Business Overview
Table 70. Sanofi Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Sanofi Prostate Cancer Drugs Product
Table 72. Sanofi Recent Developments/Updates
Table 73. GlaxoSmithKline Corporation Information
Table 74. GlaxoSmithKline Description and Business Overview
Table 75. GlaxoSmithKline Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. GlaxoSmithKline Prostate Cancer Drugs Product
Table 77. GlaxoSmithKline Recent Developments/Updates
Table 78. Merck Group Corporation Information
Table 79. Merck Group Description and Business Overview
Table 80. Merck Group Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Merck Group Prostate Cancer Drugs Product
Table 82. Merck Group Recent Developments/Updates
Table 83. Novartis Corporation Information
Table 84. Novartis Description and Business Overview
Table 85. Novartis Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. Novartis Prostate Cancer Drugs Product
Table 87. Novartis Recent Developments/Updates
Table 88. Amgen Corporation Information
Table 89. Amgen Description and Business Overview
Table 90. Amgen Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Amgen Prostate Cancer Drugs Product
Table 92. Amgen Recent Developments/Updates
Table 93. Bayer HealthCare Corporation Information
Table 94. Bayer HealthCare Description and Business Overview
Table 95. Bayer HealthCare Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. Bayer HealthCare Prostate Cancer Drugs Product
Table 97. Bayer HealthCare Recent Developments/Updates
Table 98. Ferring Pharmaceutical Corporation Information
Table 99. Ferring Pharmaceutical Description and Business Overview
Table 100. Ferring Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 101. Ferring Pharmaceutical Prostate Cancer Drugs Product
Table 102. Ferring Pharmaceutical Recent Developments/Updates
Table 103. Janssen Pharmaceuticals Corporation Information
Table 104. Janssen Pharmaceuticals Description and Business Overview
Table 105. Janssen Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 106. Janssen Pharmaceuticals Prostate Cancer Drugs Product
Table 107. Janssen Pharmaceuticals Recent Developments/Updates
Table 108. Endo Pharmaceuticals Corporation Information
Table 109. Endo Pharmaceuticals Description and Business Overview
Table 110. Endo Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 111. Endo Pharmaceuticals Prostate Cancer Drugs Product
Table 112. Endo Pharmaceuticals Recent Developments/Updates
Table 113. BMS Corporation Information
Table 114. BMS Description and Business Overview
Table 115. BMS Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 116. BMS Prostate Cancer Drugs Product
Table 117. BMS Recent Developments/Updates
Table 118. Takeda Pharmaceuticals Corporation Information
Table 119. Takeda Pharmaceuticals Description and Business Overview
Table 120. Takeda Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 121. Takeda Pharmaceuticals Prostate Cancer Drugs Product
Table 122. Takeda Pharmaceuticals Recent Developments/Updates
Table 123. Northwest Biotherapeutics Corporation Information
Table 124. Northwest Biotherapeutics Description and Business Overview
Table 125. Northwest Biotherapeutics Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 126. Northwest Biotherapeutics Prostate Cancer Drugs Product
Table 127. Northwest Biotherapeutics Recent Developments/Updates
Table 128. Teva Pharmaceutical Corporation Information
Table 129. Teva Pharmaceutical Description and Business Overview
Table 130. Teva Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 131. Teva Pharmaceutical Prostate Cancer Drugs Product
Table 132. Teva Pharmaceutical Recent Developments/Updates
Table 133. Boehringer Ingelheim Corporation Information
Table 134. Boehringer Ingelheim Description and Business Overview
Table 135. Boehringer Ingelheim Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 136. Boehringer Ingelheim Prostate Cancer Drugs Product
Table 137. Boehringer Ingelheim Recent Developments/Updates
Table 138. Foresee Pharmaceuticals Corporation Information
Table 139. Foresee Pharmaceuticals Description and Business Overview
Table 140. Foresee Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 141. Foresee Pharmaceuticals Prostate Cancer Drugs Product
Table 142. Foresee Pharmaceuticals Recent Developments/Updates
Table 143. Tokai Pharmaceuticals Corporation Information
Table 144. Tokai Pharmaceuticals Description and Business Overview
Table 145. Tokai Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 146. Tokai Pharmaceuticals Prostate Cancer Drugs Product
Table 147. Tokai Pharmaceuticals Recent Developments/Updates
Table 148. Spectrum Pharmaceuticals Corporation Information
Table 149. Spectrum Pharmaceuticals Description and Business Overview
Table 150. Spectrum Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 151. Spectrum Pharmaceuticals Prostate Cancer Drugs Product
Table 152. Spectrum Pharmaceuticals Recent Developments/Updates
Table 153. Production Base and Market Concentration Rate of Raw Material
Table 154. Key Suppliers of Raw Materials
Table 155. Prostate Cancer Drugs Distributors List
Table 156. Prostate Cancer Drugs Customers List
Table 157. Prostate Cancer Drugs Market Trends
Table 158. Prostate Cancer Drugs Growth Drivers
Table 159. Prostate Cancer Drugs Market Challenges
Table 160. Prostate Cancer Drugs Market Restraints
Table 161. Global Prostate Cancer Drugs Sales Forecast by Type (2022-2027) & (K MT)
Table 162. Global Prostate Cancer Drugs Sales Market Share Forecast by Type (2022-2027)
Table 163. Global Prostate Cancer Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 164. Global Prostate Cancer Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 165. Global Prostate Cancer Drugs Sales Forecast by Application (2022-2027) & (K MT)
Table 166. Global Prostate Cancer Drugs Sales Market Share Forecast by Application (2022-2027)
Table 167. Global Prostate Cancer Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 168. Global Prostate Cancer Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 169. Global Prostate Cancer Drugs Sales Forecast by Region (2022-2027) & (K MT)
Table 170. Global Prostate Cancer Drugs Sales Market Share Forecast by Region (2022-2027)
Table 171. Global Prostate Cancer Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 172. Global Prostate Cancer Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Prostate Cancer Drugs
Figure 2. Global Prostate Cancer Drugs Market Share by Type in 2020 & 2027
Figure 3. Hormonal Therapy Product Picture
Figure 4. Chemotherapy Product Picture
Figure 5. Immunotherapy Product Picture
Figure 6. Targeted Therapy Product Picture
Figure 7. Global Prostate Cancer Drugs Market Share by Application in 2020 & 2027
Figure 8. Clinics
Figure 9. Hospitals
Figure 10. Others
Figure 11. Global Prostate Cancer Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Prostate Cancer Drugs Market Size 2016-2027 (US$ Million)
Figure 13. Global Prostate Cancer Drugs Sales 2016-2027 (K MT)
Figure 14. Global Prostate Cancer Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Prostate Cancer Drugs Sales Share by Manufacturers in 2020
Figure 16. Global Prostate Cancer Drugs Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Prostate Cancer Drugs Players: Market Share by Revenue in 2020
Figure 18. Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Prostate Cancer Drugs Sales Market Share by Region (2016-2021)
Figure 20. Global Prostate Cancer Drugs Sales Market Share by Region in 2020
Figure 21. Global Prostate Cancer Drugs Revenue Market Share by Region (2016-2021)
Figure 22. Global Prostate Cancer Drugs Revenue Market Share by Region in 2020
Figure 23. U.S. Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. China Taiwan Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Prostate Cancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Prostate Cancer Drugs by Type (2016-2021)
Figure 46. Sales Market Share of Prostate Cancer Drugs by Application (2016-2021)
Figure 47. Sales Market Share of Prostate Cancer Drugs by Application in 2020
Figure 48. Revenue Share of Prostate Cancer Drugs by Application (2016-2021)
Figure 49. Revenue Share of Prostate Cancer Drugs by Application in 2020
Figure 50. Manufacturing Cost Structure of Prostate Cancer Drugs
Figure 51. Manufacturing Process Analysis of Prostate Cancer Drugs
Figure 52. Prostate Cancer Drugs Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed